The atrial pacemaker: retrospective analysis of complications and life expectancy in patients with sinus node dysfunction

The safety of atrial pacemakers is still a remaining cause of controversy. Since 1972, we have implanted 111 atrial pacemakers and we were able to follow-up 100 patients continuously. Mean follow-up time was 47 ± 36 months (maximum 154 months) with a total population time of 391 patient years. Over a period of 10 years, the cumulative incidence of complete atrioventricular block was 4% (2 patients). The cumulative incidence of atrial fibrillation was 11% (5 patients). Lead-related complications were strongly dependent on the type of the lead and the mode of fixation. The cumulative incidence of all lead-related problems was 19% over a period of 5 years and 33% over a period of 10 years. The cumulative survival rate was 85% for 5 years and 61% for 10 years. These survival rates were not different from the survival rate of a matched cohort of the normal population. We conclude that atrial pacing could be done in patients with sick sinus syndrome. The risk of developing a complete atrioventricular block seems to be rather low. The main problem of the atrial pacemaker is the fixation of the lead which could be reduced by using screw-in-type leads.